Solriamfetol

MedicationExperimental0 reviews

—

Average score out of 5

Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.

Solriamfetol is a wake-promoting agent used to treat excessive daytime sleepiness in narcolepsy. It is being investigated in clinical trials for its potential to alleviate severe fatigue and brain fog in Long COVID.

Information

Subcategory: dopamine and norepinephrine reuptake inhibitor (DNRI)
Evidence level: 2/5
Evidence type: ongoing randomized controlled trials

Share your experience

Your feedback helps thousands of people find what really works.

Join the community